The Korean company introduced the technology at Plastic Surgery The Meeting (PSTM) 2025, held in New Orleans, USA.  

Building on its existing diabetic foot-ulcer regeneration programme, the new platform applies artificial intelligence to analyse post-excision defects and produce a patient-specific patch using a 3D bioprinter. Once implanted, the patch promotes tissue growth that mirrors the surrounding skin, supporting faster healing and improved cosmetic outcomes.  

According to ROKIT, the system targets complete regeneration of tissue lost to non-melanoma skin cancer and has shown successful results even in older patients, who typically heal more slowly. “This technology significantly accelerates patient recovery and delivers outstanding cosmetic results,” said Professor James J. Yoo of Wake Forest University School of Medicine, in a statement released by the company.